ARMISTICE CAPITAL LLC 13D and 13G filings for Protagenic Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:19 pm Unchanged | 2024-09-30 | 13G | Protagenic Therapeutics, Inc. PTIX | ARMISTICE CAPITAL LLC | 240,000 5.100% | 0 (Unchanged) | Filing |
| 2024-02-14 2:29 pm Purchase | 2023-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | ARMISTICE CAPITAL LLC | 240,000 5.130% | 240,000 (New Position) | Filing |